Abstract
Due to an oversight of the corresponding author, the list of authors was originally published incorrectly in the manuscript entitled “Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease”, published in Current Alzheimer Research, volume 12, no. 4, 2015, pp. 298-313.
Due to this oversight, the correct first author was omitted from the original byline. The correct list of authors, with the true first author, is provided below:
Authors: Peter Cao, Nady Braidy, Martin Zarka, Jeffrey Welch and Wallace Bridge.
Affiliation: School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Syd-ney, Australia, NSW 2052.
Current Alzheimer Research
Title:Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease
Volume: 13 Issue: 10
Author(s):
Affiliation:
Abstract: Due to an oversight of the corresponding author, the list of authors was originally published incorrectly in the manuscript entitled “Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease”, published in Current Alzheimer Research, volume 12, no. 4, 2015, pp. 298-313.
Due to this oversight, the correct first author was omitted from the original byline. The correct list of authors, with the true first author, is provided below:
Authors: Peter Cao, Nady Braidy, Martin Zarka, Jeffrey Welch and Wallace Bridge.
Affiliation: School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Syd-ney, Australia, NSW 2052.
Export Options
About this article
Cite this article as:
, Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease, Current Alzheimer Research 2016; 13 (10) . https://dx.doi.org/10.2174/156720501310160825221218
DOI https://dx.doi.org/10.2174/156720501310160825221218 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Direct Correlation between Red Blood Cell Indices and Cognitive Impairment After Aneurysmal Subarachnoid Hemorrhage (aSAH)
Current Neurovascular Research Development of Pramipexole Hydrochloride Nanocrystals and their Characterization based on <I>In vitro</I> Dissolution Studies
Current Nanomedicine Progesterone/Progestagens to Prevent Preterm Birth: When and How
Current Women`s Health Reviews Evaluation of a Reporter Gene Assay for Bioactivity Determination of Therapeutic Interferons through a Collaborative Study
Current Pharmaceutical Analysis Pharmacological Approaches for Treatment-resistant Bipolar Disorder
Current Neuropharmacology Peptoids: Bio-Inspired Polymers as Potential Pharmaceuticals
Current Pharmaceutical Design The GABAergic System and the Gastrointestinal Physiopathology
Current Pharmaceutical Design Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines
Current Topics in Medicinal Chemistry The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory Response
Current Molecular Pharmacology Recent Patents on Perovskite Ferroelectric Nanostructures
Recent Patents on Nanotechnology Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets Dehydroepiandrosterone (DHEA): A Steroid with Multiple Effects. Is there Any Possible Option in the Treatment of Critical illness?
Current Medicinal Chemistry PET Imaging of Opioid Receptors in Pain: Progress and New Directions
Current Pharmaceutical Design An Efficient and Environmentally Benign Access Towards Synthesis of Novel 1,2,3-Triazolyl-pyrazoline Hybrids
Letters in Organic Chemistry MiR-125b-5p Inhibitor Might Protect Against Sevoflurane-induced Cognitive Impairments by Targeting LIMK1
Current Neurovascular Research Preface
Current Neuropharmacology Immune Abnormalities and Endotoxemia in Patients with Ulcerative Colitis and in Their First Degree Relatives: Attempts at Neutralizing Endotoxin- Mediated Effects
Current Pharmaceutical Design Matter of Life and Death: the Pharmacological Approaches Targeting Apoptosis in Brain Diseases
Current Pharmaceutical Design Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia
Current Neuropharmacology Mother-Daughter Reunification in Adolescence: Another Trauma, Another Chance
Adolescent Psychiatry